Remdesivir for patients with COVID-19

被引：1
|
作者：
Wu, Peter E. [1 ,2 ,4 ]
Morris, Andrew M. [1 ,3 ,5 ]
机构：
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Div Clin Pharmacol & Toxicol, Toronto, ON, Canada
[3] Univ Toronto, Div Infect Dis, Toronto, ON, Canada
[4] Univ Hlth Network, Div Gen Internal Med & Geriatr, Toronto, ON, Canada
[5] Sinai Hlth, Div Infect Dis, Toronto, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2021年 / 193卷 / 04期
关键词：
D O I：
10.1503/cmaj.202505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E125 / E125
页数：1
相关论文
共 50 条
  • [41] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Vitiello, Antonio
    Ferrara, Francesco
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1249 - 1250
  • [42] Use of remdesivir for COVID-19 in patients with hematologic cancer
    Alexandra Martin-Onraët
    Corazón Barrientos-Flores
    Diana Vilar-Compte
    Carolina Pérez-Jimenez
    Pamela Alatorre-Fernandez
    Clinical and Experimental Medicine, 2023, 23 : 2231 - 2238
  • [43] Liver injury in remdesivir-treated COVID-19 patients
    Rosa Zampino
    Ferruccio Mele
    Letizia Lucia Florio
    Lorenzo Bertolino
    Roberto Andini
    Maria Galdo
    Rosanna De Rosa
    Antonio Corcione
    Emanuele Durante-Mangoni
    Hepatology International, 2020, 14 : 881 - 883
  • [44] Remdesivir in COVID-19 Patients with Impaired Renal Function Reply
    Adamsick, Meagan L.
    Bhattacharyya, Roby P.
    Sise, Meghan E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (02): : 519 - 520
  • [45] Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
    Goldman, Jason D.
    Lye, David C. B.
    Hui, David S.
    Marks, Kristen M.
    Bruno, Raffaele
    Montejano, Rocio
    Spinner, Christoph D.
    Galli, Massimo
    Ahn, Mi-Young
    Nahass, Ronald G.
    Chen, Yao-Shen
    SenGupta, Devi
    Hyland, Robert H.
    Osinusi, Anu O.
    Cao, Huyen
    Blair, Christiana
    Wei, Xuelian
    Gaggar, Anuj
    Brainard, Diana M.
    Towner, William J.
    Munoz, Jose
    Mullane, Kathleen M.
    Marty, Francisco M.
    Tashima, Karen T.
    Diaz, George
    Subramanian, Aruna
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19): : 1827 - 1837
  • [46] Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients
    Butt, Batool
    Hussain, Tajamul
    Jarrar, Mu'taman
    Khalid, Kashaf
    Albaker, Waleed
    Ambreen, Asma
    Waheed, Yasir
    ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [47] Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy
    Jaroszewicz, Jerzy
    Kowalska, Justyna
    Pawlowska, Malgorzata
    Rogalska, Magdalena
    Zarebska-Michaluk, Dorota
    Rorat, Marta
    Lorenc, Beata
    Czupryna, Piotr
    Sikorska, Katarzyna
    Piekarska, Anna
    Dworzanska, Anna
    Zaleska, Izabela
    Mazur, Wlodzimierz
    Kozielewicz, Dorota
    Klos, Krzysztof
    Podlasin, Regina
    Angielski, Grzegorz
    Oczko-Grzesik, Barbara
    Figlerowicz, Magdalena
    Szetela, Bartosz
    Bolewska, Beata
    Franczak-Chmura, Paulina
    Flisiak, Robert
    Tomasiewicz, Krzysztof
    CANCERS, 2022, 14 (19)
  • [48] The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
    Whittington, Melanie D.
    Pearson, Steven D.
    Rind, David M.
    Campbell, Jonathan D.
    VALUE IN HEALTH, 2022, 25 (05) : 744 - 750
  • [49] COVID-19 and remdesivir in pediatric patients: the invisible part of the iceberg
    Yalcin, Nadir
    Demirkan, Kutay
    PEDIATRIC RESEARCH, 2021, 89 (06) : 1326 - 1327
  • [50] Liver and kidney function in patients with Covid-19 treated with remdesivir
    van Laar, Sylvia A.
    de Boer, Mark G. J.
    Gombert-Handoko, Kim B.
    Guchelaar, Henk-Jan
    Zwaveling, Juliette
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4450 - 4454
12345